Bravura 发表于 2025-3-25 05:36:32

http://reply.papertrans.cn/1/95/9417/9417-21.png

IRK 发表于 2025-3-25 08:22:56

http://reply.papertrans.cn/1/95/9417/9417-22.png

Conclave 发表于 2025-3-25 13:44:02

http://reply.papertrans.cn/1/95/9417/9417-23.png

遗传学 发表于 2025-3-25 18:50:43

http://reply.papertrans.cn/1/95/9417/9417-24.png

hegemony 发表于 2025-3-25 20:26:34

Submitted on: 11 January 2015.
Revised on: 30 March 2015.
Accepted on: 20 May 2015.

___________________European Urology Oncology---ELSEVIER

overrule 发表于 2025-3-26 00:23:01

Submitted on: 16 June 2012.
Revised on: 30 August 2012.
Accepted on: 27 October 2012.

___________________European Urology Oncology---ELSEVIER

Lumbar-Spine 发表于 2025-3-26 04:47:04

http://reply.papertrans.cn/1/95/9417/9417-27.png

creditor 发表于 2025-3-26 10:54:16

Submitted on: 12 February 2005.
Revised on: 07 March 2005.
Accepted on: 28 April 2005.

___________________European Urology Oncology---ELSEVIER

人类的发源 发表于 2025-3-26 14:36:46

http://reply.papertrans.cn/1/95/9417/9417-29.png

Terrace 发表于 2025-3-26 20:12:08

Submitted on: 29 October 2009.
Revised on: 27 November 2009.
Accepted on: 22 December 2009.

___________________European Urology Oncology---ELSEVIER
页: 1 2 [3] 4
查看完整版本: SCIE期刊European Urology Oncology 2024/2025影响因子:8.337 (EUR UROL ONCOL) (NULL). (ONCOLOGY)(肿瘤学)Science Citation Index Expa